Skip to main navigation Skip to search Skip to main content

Long-term Safety of Apremilast Treatment in Psoriasis and Psoriatic Arthritis Patients: Pooled Analysis for 156 Weeks and Beyond in the ESTEEM 1 and 2 and PALACE 1‒3 Phase 3 Trials. American Academy of Dermatology (AAD) Annual Meeting, Orlando, Mar 2017.

Research output: Contribution to conference › Poster

Original languageAmerican English
StatePublished - Mar 2017
EventAmerican Academy of Dermatology (AAD) Annual Meeting -
Duration: Mar 1 2017 → …

Conference

ConferenceAmerican Academy of Dermatology (AAD) Annual Meeting
Period03/1/17 → …

Disciplines

  • Rheumatology

Cite this